Benfang Helen Ruan

Benfang Helen Ruan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
XZXiaoli Zhang
Xiaoli Zhang
WCWei Chen
Wei Chen
QGQiong Gao
Qiong Gao
JYJunsheng Yang
Junsheng Yang
XYXueni Yan
Xueni Yan
HXHaoxing Xu
Haoxing Xu
Rapamycin (Rap) and its derivatives, called rapalogs, are being explored in clinical trials targeting cancer and neurodegeneration. The underlying mechanisms of Rap actions, however, are not well understood. Mechanistic target of rapamycin (mTOR), a lysosome-localized protein kinase that acts as a critical regulator of cellular growth, is believed to mediate most Rap actions. Here, we identified mucolipin 1 (transient receptor potential channel mucolipin 1 [TRPML1], also known as MCOLN1), the principle Ca2+ release channel in the lysosome, as another direct target of Rap. Patch-clamping of isolated lysosomal membranes showed that micromolar concentrations of Rap and some rapalogs activated lysosomal TRPML1 directly and specifically. Pharmacological inhibition or genetic inactivation of mTOR failed to mimic the Rap effect. In vitro binding assays revealed that Rap bound directly to purified TRPML1 proteins with a micromolar affinity. In both healthy and disease human fibroblasts, Rap and rapalogs induced autophagic flux via nuclear translocation of transcription factor EB (TFEB). However, such effects were abolished in TRPML1-deficient cells or by TRPML1 inhibitors. Hence, Rap and rapalogs promote autophagy via a TRPML1-dependent mechanism. Given the demonstrated roles of TRPML1 and TFEB in cellular clearance, we propose that lysosomal TRPML1 may contribute a significant portion to the in vivo neuroprotective and anti-aging effects of Rap via an augmentation of autophagy and lysosomal biogenesis.

13 December 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZCZhao Chen
Zhao Chen
DLDi Li
Di Li
NXNing Xu
Ning Xu
JFJinzhang Fang
Jinzhang Fang
YYYan Yu
Yan Yu
BRBenfang Helen Ruan
Benfang Helen Ruan

26 January 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
MZMin Zhu
Min Zhu
JFJinzhang Fang
Jinzhang Fang
JZJingjing Zhang
Jingjing Zhang
ZZZheng Zhang
Zheng Zhang
JXJianhui Xie
Jianhui Xie
BRBenfang Helen Ruan
Benfang Helen Ruan

7 November 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
YYYan Yu
Yan Yu
YJYanhong Jin
Yanhong Jin
JZJie Zhou
Jie Zhou
HRHaoqiang Ruan
Haoqiang Ruan
HZHan Zhao
Han Zhao
BRBenfang Helen Ruan
Benfang Helen Ruan

22 February 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WWWenxi Wang
Wenxi Wang
ASAnna Shao
Anna Shao
NZNan Zhang
Nan Zhang
JFJinzhang Fang
Jinzhang Fang
JRJennifer Jin Ruan
Jennifer Jin Ruan
BRBenfang Helen Ruan
Benfang Helen Ruan
Liposome (LP) encapsulation of doxorubicin (DOX) is a clinically validated method for cancer drug delivery, but its cellular uptake is actually lower than the free DOX. Therefore, we modified DOX-LP with a cationic polymer (Eudragit RL100; ER) to improve its cellular uptake and antitumor activity. The resulting DOX-ERLP was a 190 nm nanoparticle that was absorbed efficiently and caused cancer cell death in 5 hrs. Growth as measured by the MTT assay or microscopic imaging demonstrated that DOX-ERLP has at least a two-fold greater potency than the free DOX in inhibiting the growth of a DOX resistant (MCF7/adr) cell and an aggressive liver cancer H22 cell. Further, its in vivo efficacy was tested in H22-bearing mice, where four injections of DOX-ERLP reduced the tumor growth by more than 60% and caused an average of 60% tumor necrosis, which was significantly better than the DOX and DOX-LP treated groups. Our work represents the first use of polymethacrylate derivatives for DOX liposomal delivery, demonstrating the great potential of cationic polymethacrylate modified liposomes for improving cancer drug delivery.

1 September 2016 in Analytical Biochemistry
Verified
Journal Article
Closed access
WZWei Zhang
Wei Zhang
MZMin Zhu
Min Zhu
FWFeng Wang
Feng Wang
DCDanhui Cao
Danhui Cao
JRJennifer Jin Ruan
Jennifer Jin Ruan
BRBenfang Helen Ruan
Benfang Helen Ruan